Study S001004

Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00622323
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 41
Start: 2008-02
Primary completion: 2009-09
Lead sponsor: AstraZeneca
Conditions: Type 2 Diabetes Mellitus
Results posted: FALSE
Secondary identifiers: OTHER:H8O-PH-B006

Registered primary outcomes

To determine the proportion of patients experiencing an adverse event and a list of the experienced adverse events, that would occur among Filipino patients with type 2 diabetes and inadequate glycemic control treated with exenatide [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.